Documents detail price hike decisions by Turing, Valeant
Federal lawmakers have released excerpts from thousands of documents detailing how two drugmakers hiked prices to squeeze more revenue from some life-saving medicines, a practice that has recently sparked public outrage. The congressional review of more than 300,000 pages from Turing Pharmaceuticals and Valeant Pharmaceuticals highlights the internal strategies the companies used to dramatically raise […]
Read more »